Correction: Can fecal calprotectin be used as a biomarker of non-alcoholic fatty liver disease in obese adolescents?

• Büşra Tetik Dinçer,
• Ayşe Merve Usta,
• Alev Kural,
• Nazlı Helvacı,
• Ahmet Uçar,
• Nafiye Urgancı

Affiliations

Büşra Tetik Dinçer

Department of Pediatrics, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences

Ayşe Merve Usta

Department of Pediatrics, Division of Pediatric Gastroenterology, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences

Alev Kural

Department of Biochemistry, Bakırkoy Sadi Konuk Training and Research Hospital, University of Health Sciences

Nazlı Helvacı

Department of Biochemistry, Bakırkoy Sadi Konuk Training and Research Hospital, University of Health Sciences

Ahmet Uçar

Department of Pediatrics, Division of Pediatric Endocrinology, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences

Nafiye Urgancı

Department of Pediatrics, Division of Pediatric Gastroenterology, Sisli Hamidiye Etfal Training and Research Hospital, University of Health Sciences